| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2002;33:1963.)
© 2002 American Heart Association, Inc.
Original Contributions |
From Hennepin County Medical Center and University of Minnesota, Minneapolis (D.C.A.); University Medical Center Utrecht, Utrecht, the Netherlands (L.J.K.); John P. Robarts Research Institute (M.E., H.J.M.B.) and Department of Epidemiology and Biostatistics (M.E.), University of Western Ontario, London, Ontario, Canada; Boston University School of Medicine, Boston, Mass (V.L.B.); and Axio Research Corporation, Seattle, Wash (L.A.P.).
Reprint requests to David C. Anderson, MD, Hennepin County Medical Center, Department of Neurology, 701 Park Ave S, Minneapolis, MN 55415. E-mail ander012{at}tc.umn.edu
Background and Purpose The goal of this study was to examine the hypotheses that retinal ischemia is caused more often by carotid atherosclerosis than by atrial fibrillation and that the odds of retinal events compared with hemispheric events increase with worsening carotid stenosis.
Methods We used data from the Stroke Prevention in Atrial Fibrillation (SPAF) I through III trials and North American Symptomatic Carotid Endarterectomy Trial (NASCET), calculating hemispheric:retinal (H:R) odds for the territory of ischemic events during follow-up in patients with atrial fibrillation and medically treated 50% to 99% carotid stenosis or occlusion in the respective trials.
Results The H:R odds were 25:1 in the SPAF aspirin-assigned patients and 2:1 for NASCET vessels. In NASCET patients, the H:R odds of recurrent ischemic events were 1:4 for vessels randomized initially for retinal symptoms compared with 6:1 for those randomized for hemispheric events (significant difference; P<0.001). Moreover, the H:R odds of first events in the territory of the contralateral asymptomatic artery were 1:1 if the randomized vessel had retinal symptoms compared with 4:1 if the randomized vessel had hemispheric symptoms (significant difference; P<0.01). Increasing carotid stenosis in the 50% to 99% range had no effect on H:R odds (P=0.8).
Conclusions These findings confirm that retinal symptoms are more typical of carotid stenosis. Hemodynamic effects do not appear to be more important in the pathogenesis of retinal events than hemispheric ones in carotid stenosis. The retinal versus hemispheric location of initial symptoms is strongly predictive of the location of subsequent events in patients with carotid stenosis, even when new symptoms are contralateral to the original ones.
This article has been cited by other articles:
![]() |
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L Bayard, S. H Ostermayer, and H. Sievert Alternatives to warfarin in atrial fibrillation: drugs and devices Heart, September 1, 2008; 94(9): 1113 - 1116. [Full Text] [PDF] |
||||
![]() |
I. Thyer, P. Kovoor, J. J. Wang, B. Taylor, A. Kifley, R. Lindley, P. Mitchell, and A. Thiagalingam Coronary Catheterisation Does Not Lead to Retinal Artery Emboli in Short-Term Follow-Up of Cardiac Patients Stroke, August 1, 2007; 38(8): 2370 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
E L L M De Schryver, A Algra, R C J M Donders, J van Gijn, and L J Kappelle Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 734 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Hart, L. A. Pearce, and P. J. Koudstaal Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial Stroke, April 1, 2004; 35(4): 948 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Hart, J. L. Halperin, L. A. Pearce, D. C. Anderson, R. A. Kronmal, R. McBride, E. Nasco, D. G. Sherman, R. L. Talbert, J. R. Marler, et al. Lessons from the Stroke Prevention in Atrial Fibrillation Trials Ann Intern Med, May 20, 2003; 138(10): 831 - 838. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |